61 followers
A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with... http://t.co/wyQa8Rj2Ze
A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with... http://t.co/wyQa8Rj2Ze